Enhanced oral bioavailability and anti-tumor effect of paclitaxel by 20(s)-Ginsenoside Rg3 in vivo.
Summary of "Enhanced oral bioavailability and anti-tumor effect of paclitaxel by 20(s)-Ginsenoside Rg3 in vivo."
The purpose of this study was to investigate the effect of paclitaxel in combination with 20(s)-Ginsenoside Rg3 on its anti-tumor effect in nude mice. In Caco-2 transport assay, P(app) (A-B) and P(app) (B-A) of paclitaxel were measured when co-incubation with different concentrations of 20(s)-Ginsenoside Rg3. Results indicated that the penetration of paclitaxel through the Caco-2 monolayer from the apical side to the basal side was facilitated by 20(s)-Ginsenoside Rg3 in a concentration-dependent manner. Meanwhile, 20(s)-Ginsenoside Rg3 inhibited P-gp, and the maximum inhibition was achieved at 80μM (P < 0.05). The pharmacokinetic parameters of paclitaxel after oral co-administration of paclitaxel (40 mg/kg) with various doses of 20(s)-Ginsenoside Rg3 in rats were investigated through in vivo pharmacokinetic experiment. The results showed that the AUC of paclitaxel co-administered with 20(s)-Ginsenoside Rg3 were significantly higher (P < 0.001 at 10 mg/kg) compared to the control. The RB % of paclitaxel with 20(s)-Ginsenoside Rg3 was 3.4-fold (10 mg/kg) higher than that of control. The effect of paclitaxel orally co-administered with 20(s)-Ginsenoside Rg3 against human tumor MCF-7 xenografts in nude mice was also evaluated. Paclitaxel (20mg/kg) co-administered with 20(s)-Ginsenoside Rg3 (10mg/kg) exhibited effective anti-tumor activity with T/C values of 39.36% (P <0.05). Our results showed that 20(s)-Ginsenoside Rg3 enhanced the oral bioavailability of paclitaxel in rats and improved the anti-tumor activity in nude mice, which indicated that orally co-administration paclitaxel with 20(s)-Ginsenoside Rg3 could provide an effective strategy in addition to the established IV route. Copyright © 2012 John Wiley & Sons, Ltd.
Affiliation
State Key Laboratory of Drug Metabolism, Hematological Pharmacology, Beijing Institute of Transfusion Medicine, 27 Taiping Road, Beijing, 100850, PR China; Laboratory of Cardiovascular Smooth Muscle, Shenyang Pharmaceutical University, 103 Wenhau Road, Sh
Journal Details
This article was published in the following journal.
Name: Biopharmaceutics & drug disposition
ISSN: 1099-081X
Pages:
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22898996
- DOI: http://dx.doi.org/10.1002/bdd.1806
Medical and Biotech [MESH] Definitions
Indinavir
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
Taxus
Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL).
Graft Vs Tumor Effect
Immunological rejection of tumor tissue/cells following bone marrow transplantation.
4,5-dihydro-1-(3-(trifluoromethyl)phenyl)-1h-pyrazol-3-amine
A dual inhibitor of both cyclooxygenase and lipoxygenase pathways. It exerts an anti-inflammatory effect by inhibiting the formation of prostaglandins and leukotrienes. The drug also enhances pulmonary hypoxic vasoconstriction and has a protective effect after myocardial ischemia.
Placebo Effect
An effect usually, but not necessarily, beneficial that is attributable to an expectation that the regimen will have an effect, i.e., the effect is due to the power of suggestion.
PubMed Articles
Paclitaxel is avidly transported by P-glycoprotein (P-gp/MDR1/ABCB1/rpar;. This results in low oral bioavailability, which can be boosted by co-administration of P-gp inhibitors. Unlike paclitaxel, do...
Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.
The aims of the present study were to investigate the effects of silymarin, an inhibitor of the P-glycoprotein efflux pump, on oral bioavailability of paclitaxel in rats, and to compare pharmacokineti...
Development of Lipid-Based Nanoparticles for Enhancing the Oral Bioavailability of Paclitaxel.
The current research work investigates the potential of solid lipid nanoparticles (SLNs) in improving the oral bioavailability of paclitaxel. Paclitaxel-loaded SLNs (PTX-SLNs) were prepared by modifie...
Nanoparticle Albumin Bound Paclitaxel Retargeted to Radiation Inducible TIP-1 in Cancer.
PURPOSE: Purpose: The purpose of this study was to achieve improved cancer-specific delivery and bioavailability of radiation-sensitizing chemotherapy using radiation-guided drug delivery.EXPERIMENTAL...
The pharmacological bases of the antiangiogenic activity of paclitaxel.
In the mid 1990s, researchers began to investigate the antiangiogenic activity of paclitaxel as a possible additional mechanism contributing to its antineoplastic activity in vivo. In the last decade,...
Clinical Trials
Efficacy and Safety of Ginsenoside-Rd for Acute Ischemic Stroke
The purpose of this phase 3 study is to validate the efficacy and safety of ginsenoside-Rd for acute ischemic stroke.
This study will evaluate the relative bioavailability of 2 oral formulations of TKI258, and the effect of food on the bioavailability of TKI258, in adult patients with advanced solid tumor...
This study will evaluate the relative bioavailability of 2 oral formulations of TKI258, and the effect of food on the bioavailability of TKI258, in adult patients with advanced solid tumor
Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers
Description: To investigate bioavailability of two anti-viral drugs (lamivudine and zidovudine) from a new oral formulation (trial formulation) especially designed for pediatric use....
To characterize the pharmacokinetics of orally administered FLT (in a liquid formulation) after single doses in both the fed and fasting states; to assess the effect of food on the oral bi...
